The Association for Accessible Medicines (AAM) has issued a white paper urging the US Food and Drug Administration (FDA) and other policymakers to adopt long-term sustainable solutions in addressing the current drug shortages. These solutions must address ensuring a sustainable generic market, increasing reserves of critical medicines, and reducing regulatory and manufacturing challenges for generic drugs, AAM said.
The white paper details the extent of the problem, some of the factors that are prompting drug shortages, and offers potential solutions…
